长COVID:神经系统表现--最新叙述性综述。

Q3 Medicine Dementia e Neuropsychologia Pub Date : 2024-02-09 eCollection Date: 2024-01-01 DOI:10.1590/1980-5764-DN-2023-0076
José Wagner Leonel, Gabriella Cunha Vieira Ciurleo, Alissa Moura Formiga, Thais de Maria Frota Vasconcelos, Marcello Holanda de Andrade, Werbety Lucas Queiroz Feitosa, Antônio Alves Sobreira-Neto, Chiara Gübel Portugal, Lorenzo Marinho Morais, Samuel Cavalcante Marinho, Emanuel de Assis Bertulino Martins Gomes, Esther de Alencar Araripe Falcão Feitosa, Emmanuelle Silva Tavares Sobreira, Reinaldo Barreto Oriá, Manoel Alves Sobreira-Neto, Pedro Braga-Neto
{"title":"长COVID:神经系统表现--最新叙述性综述。","authors":"José Wagner Leonel, Gabriella Cunha Vieira Ciurleo, Alissa Moura Formiga, Thais de Maria Frota Vasconcelos, Marcello Holanda de Andrade, Werbety Lucas Queiroz Feitosa, Antônio Alves Sobreira-Neto, Chiara Gübel Portugal, Lorenzo Marinho Morais, Samuel Cavalcante Marinho, Emanuel de Assis Bertulino Martins Gomes, Esther de Alencar Araripe Falcão Feitosa, Emmanuelle Silva Tavares Sobreira, Reinaldo Barreto Oriá, Manoel Alves Sobreira-Neto, Pedro Braga-Neto","doi":"10.1590/1980-5764-DN-2023-0076","DOIUrl":null,"url":null,"abstract":"<p><p>Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.</p>","PeriodicalId":39167,"journal":{"name":"Dementia e Neuropsychologia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10901563/pdf/","citationCount":"0","resultStr":"{\"title\":\"Long COVID: neurological manifestations - an updated narrative review.\",\"authors\":\"José Wagner Leonel, Gabriella Cunha Vieira Ciurleo, Alissa Moura Formiga, Thais de Maria Frota Vasconcelos, Marcello Holanda de Andrade, Werbety Lucas Queiroz Feitosa, Antônio Alves Sobreira-Neto, Chiara Gübel Portugal, Lorenzo Marinho Morais, Samuel Cavalcante Marinho, Emanuel de Assis Bertulino Martins Gomes, Esther de Alencar Araripe Falcão Feitosa, Emmanuelle Silva Tavares Sobreira, Reinaldo Barreto Oriá, Manoel Alves Sobreira-Neto, Pedro Braga-Neto\",\"doi\":\"10.1590/1980-5764-DN-2023-0076\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.</p>\",\"PeriodicalId\":39167,\"journal\":{\"name\":\"Dementia e Neuropsychologia\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10901563/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Dementia e Neuropsychologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1590/1980-5764-DN-2023-0076\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dementia e Neuropsychologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/1980-5764-DN-2023-0076","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

感染 SARS-CoV-2 病毒可在急性期和长 COVID 期导致神经系统症状。这些症状通常涉及认知、睡眠、嗅觉障碍、精神表现、头痛等。这种情况多见于青壮年和女性。这种症状可能出现在重症病例中,也可能出现在轻症病例中。这一问题的重要性在于长 COVID 阶段神经系统症状的高发病率,这给这一人群带来了巨大的发病率。此外,这种疾病与高昂的医疗费用有关,据估计约为 3.7 万亿美元。在本综述中,我们将依次介绍目前对长 COVID 最常见神经症状的了解,以及这些症状的病理生理学和可能的生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Long COVID: neurological manifestations - an updated narrative review.

Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Dementia e Neuropsychologia
Dementia e Neuropsychologia Medicine-Geriatrics and Gerontology
CiteScore
2.20
自引率
0.00%
发文量
58
审稿时长
8 weeks
期刊介绍: Dementia top Neuropsychologia the official scientific journal of the Cognitive Neurology and Ageing Department of the Brazilian Academy of Neurology and of the Brazilian Association of Geriatric Neuropsychiatry, is published by the "Associação Neurologia Cognitiva e do Comportamento", a nonprofit Brazilian association. Regularly published on March, June, September, and December since 2007.
期刊最新文献
Brain morphometry in transient global amnesia: a triangulated analysis approach. Executive functions, mental health, and quality of life in healthy older adults. Guidelines for the use and interpretation of Alzheimer's disease biomarkers in clinical practice in Brazil: recommendations from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Use of anti-amyloid therapies for Alzheimer's disease in Brazil: a position paper from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Caring for people with dementia during the COVID-19 pandemic:a systematic review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1